The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease.

London-listed emerging graphite miner Blencowe Resources has announced a retail offer through a bookbuild of new ordinary shares valued at £195 000, as well as the successful raising of £1.5-million ...